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Abstract
Analyzing electronic health records (EHR) poses significant challenges because
often few samples are available describing a patient’s health and, when available,
their information content is highly diverse. The problem we consider is how to
integrate sparsely sampled longitudinal data, missing measurements informative
of the underlying health status and fixed demographic information to produce
estimated survival distributions updated through a patient’s follow up. We propose
a nonparametric probabilistic model that generates survival trajectories from an
ensemble of Bayesian trees that learns variable interactions over time without spec-
ifying beforehand the longitudinal process. We show performance improvements
on Primary Biliary Cirrhosis patient data.
1 Introduction
Clinical prognostic models derived from electronic medical records are an important support for
many critical diagnostic and therapeutic decisions. The majority of these models, however, do not
leverage the information contained in a patient’s history, such as tests, vital signs, and biomarkers.
Longitudinal EHR data is increasingly relevant to better understand and predict the health state of
patients [19] but remains a challenge for analysis because of irregular, sporadic sampling and high
missingness (often informatively) [8]. As an example of a typical trajectory found in EHRs we depict
in Figure 1 two longitudinal variables describing a patient suffering from liver disease.
In this paper we consider the problem of analyzing survival of patients on the basis of scarce
longitudinal data sampled irregularly over time. Modelling sparsely sampled data - arising when
intervals between observations are often large - is becoming increasingly relevant for managing
elderly patient populations due to the greater prevalence of chronic diseases that develop over a period
of years or decades [13, 25]. A substantial portion of machine learning research now investigates
prognosis with time series data, typically focusing on patients in the hospital where information
is densely collected. Predictions in this setting tend to target a binary event and require structured
and regularly sampled data [6, 15]. Modelling survival data differs from the above as data is often
recorded with censoring - a patient may drop out of a study but information up to that time is known.
Moreover, the sparsity of recorded information will tend to lead to substantial uncertainty about
model predictions which needs to be captured for reliable inference in practice [3]. We discuss
these issues and develop a Bayesian nonparametric model that aims to overcome these difficulties
by (1) quantifying the uncertainty around model predictions in a principled manner at the individual
level, while (2) avoiding to make assumptions on the data generating process and adapting model
complexity to the structure of the data. Both contributions are particularly important for personalizing
health care decisions as predictions may be uncertain due to lack of data, while we can expect the
underlying heterogeneous physiological time series to vary wildly across patients.
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Figure 1: Illustration of the available patient’s record and subsequent model survival predictions for
an exemplary patient with primary biliary cirrhosis. The left and middle panel suggest that the patient
gradually transitions from being healthy to becoming sick as elevations in bilirubin measurements
over time signal an advanced disease stage; a fact reflected in our model’s survival predictions (right
panel). The times at which survival predictions are updated are given by the red dashed lines.
2 Problem Formulation
Our goal is to analyze the occurrence of the event of interest in a medically-relevant time frame
(t, t+ ∆t]. The survival probability given survival up to time t is given by,
S(t+ ∆t; t) := P(T > t+ ∆t|T > t)
Each individual i in our population is described by an irregularly sampled time series, defined as a
sequence Xi := (Xi1, ..., Xi|ti|) of multidimensional observations (in Rd) with irregular intervals
between their observation times ti = (t1, ..., tni). We denote by Xi(s) all information available
for patient i up to time s. Our target for prediction is the time until the occurrence of the event of
interest Ti ∈ R+. For some patients this outcome may be censored (with censoring time denoted
Ci), for example if they drop out of the study. We write δi = 1 for patients experiencing the event of
interest and δi = 0 for censored patients. Let Dt denote n independent samples of the random tuple
{Xi(t), δi, δiTi + (1− δi)Ci} on which a data-driven model is to be fitted.
Note that it will also be useful to define missing data as those missing entries in the multidimensional
feature vector Xit, t ∈ ti. This is because when other information is observed at a time t, missing
risk factors may indicate a perception of reduced relevance in certain patients, as is the case with
routine measurements such as the Body Mass Index [4].
3 Model description
In this section we introduce our proposed modelling approach, termed Bayesian Nonparametric
Dynamic Survival (BNDS) model.
We represent a patient trajectory explicitly as a discrete sequence of tuples consisting of the ob-
servation times and corresponding measurements (ti,xi). For each one of these sequences, we
define event indicators wi ∈ {0, 1}|ti|, which represent the survival status of a patient i (i.e.
witij = 0 if the patient was alive at time tij). The probability of an event is described by
p(witij = 1) = p(Ti ≤ tij |Ti > tij−1).
This interpretation as conditional probabilities is especially useful to define full survival distributions.
Define a fine sequence of time windows (tk, tk+1)r=sr=k in the future. The survival probability at a
time ts in the future given survival up to time tk then is given by [18],
p(Ti > ts|Ti > tk) =
s∏
r=k+1
p(Ti > tr|Ti > tr−1) =
s∏
r=k+1
(1− p(witr = 1)) (1)
Prior model. The nonparametric nature of inference follows from first assigning a prior Π over a
random basis of regression trees hk that captures the interaction of time tr and the values of the ith
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patient variables at that time, denoted by xitr
1. For a given prior Π, the generative model proceeds as
follows: we sample k regression trees, combine them to form an ensemble and transform their output
to issue probabilities p(witr = 1) for each tuple (t, xitr−1), tr ∈ ti. In a nutshell,
h ∼ Π, pitr |h, t,xitr−1) ∼ Φ
(∑
k
hk(xir−1 , t)
)
, Witr |pitr ∼ Bern(pitr ) (2)
Φ denotes the cumulative distribution function of a standard Gaussian random variable. In the medical
setting this set up is useful as prior beliefs on the importance of risk factors for a disease, such as
diabetes, can be included in Π to encourage trees to split on that variable or to regulate the depth of
the trees based on the believed complexity of associations. Refer to the Supplement for more details.
Posterior distribution. Our observation model guides our probability model to a posterior distribu-
tion of parameters that agrees with the observed data. It is defined as follows,
p(w) =
∏
i
p(wi) =
∏
i
|ti|∏
j=1
p(witj = 1)
witj
(
1− p(witj = 1)
)1−witj (3)
We compute the posterior p(h|(wi)i) (intractable because of the large parameter space) of the set
of tree structures and leaf node parameters (M,Z) given (wi)Ni=1 via repeatedly sampling from
a tailored version of the Backfitting MCMC algorithm introduced in [5]. In a given iteration, we
proceed by subtracting from the observedwi’s the fit of the current ensemble and draw the subsequent
tree conditional on the resulting residual with a Gibbs sampler and a Metropolis step. Because we
target binary outcomes, we use a data augmentation approach [1] which introduces i.i.d. Gaussian
latent variables Vitij , i = 1, ..., N , (one for each observed patient and observation time) simulated in
an additional step in the MCMC algorithm. Let fi,tk := hk(xitk−1 , tk). Vitk is generated conditional
on the observed data witk as follows,
Vitk |witk = 1 ∼ max (N (fi,tk , 1) , 0) , Vitk |witk = 0 ∼ min (N (fi,tk , 1) , 0)
Draws from this posterior are used to sample real-valued latent variables that link the probit model
for binary outcomes with the tree regression model. This step can be inferred exactly with a Gibbs
sampler as the posterior has a well-defined closed form [12]. For an individual i having survived up to
tk, the survival probability beyond time tk+s is estimated by extrapolating along the time dimension
on this surface,
p(Ti > tk+s|Ti > tk,Dtk) :=
s∏
r=k+1
(1− p(witr = 1|Dtk)), (4)
Dtk := {Xi(tk)}Ni=1 is all patient information up to time tk. We quantify uncertainty around model
predictions by considering the quantiles of the posterior distribution, providing credible intervals,
which are especially important for heterogeneous data samples as flexible algorithms might overfit
the training data and give unreliable predictions at test time.
Informative missing values. As we have noted, missing measurements may often reflect decisions
by clinicians which implicitly provide information about the health status of the patient 2. To include
this information, we augment the space of splitting rules in the stochastic tree construction to include
missingness of a variable as a splitting criterion similarly to the approach of [21, 12]. Such a split,
if informative for survival (in the sense of increasing the likelihood of observed event times under
the current model) will be encouraged by the MCMC sampling algorithm and result in meaningful
partitions of the data based on unobserved measurements. For a possible splitting threshold δ in
the range of a patient variable z with missing values, three splitting rules are considered: (1) -
{i : zi ≤ δ or zi missing } versus {i : zi > δ}, (2) - {i : zi ≤ δ} versus {i : zi > δ or zi missing },
and (3) - {i : zi missing } versus {i : zi not missing }.
These are uniformly sampled as a potential splitting rule in the MCMC procedure. No imputation of
training or testing data is required.
1The prior on the trees itself, Π := (Z,M) = (Zk,Mk)k is composed of priors on the tree structure Z
(depth of the tree and, splitting variables and values in each node) and leaf node outputsM. We refer the reader
to [5] and the Supplement for more details.
2This setting corresponds to data missing not at random (MNAR), see [16] for more details.
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C-index on PBC data
Cox-Landmark At t = 2y 0.845± 0.010 At t = 4y 0.738± 0.056 At t = 6y 0.718± 0.031
RSF-Landmark 0.873± 0.008 0.790± 0.046 0.772± 0.032
Joint Model 0.877± 0.009 0.791± 0.041 0.787± 0.031
BNDS (ours) 0.894± 0.010 0.809± 0.043 0.805± 0.030
Table 1: Median C-index (higher better) and standard deviation using 5-fold cross-validation.
4 Experiments: Predictive performance comparisons
Data description. Primary Biliary Cirrhosis (PBC) is a slowly progressing disease of the liver
that affects approximately 0.025% of the population, the majority of which are women. Early
identification is difficult because many biomarkers are involved in its development with poorly
understood interactions [14]. We considered data from the Mayo Clinic trial used previously in [20].
A total of 312 patients were analyzed in this study of which 63% experienced liver failure, the end
point of interest. On average 6 follow-up visits were recorded during an average time to event of 6.2
years. Summary statistics are included in the Supplement.
Baseline prediction algorithms. Modelling longitudinal data to inform survival has been considered
in two statistics approaches: Joint models [2, 17, 10] and Landmarking [24, 23, 22]. Joint models
(JM) specify separate longitudinal and survival models related by shared random effects, inducing
correlation between the two and propagating the uncertainty from future longitudinal estimates
into survival predictions. Landmarking, in contrast, uses the last longitudinal measurement carried
forward as an estimate for the current longitudinal value and builds a (static) prediction model based
on these values. Its implementation consists of two steps: the construction of a cross-sectional data
set, and the development of a Cox model based on that landmark data set. We evaluate joint models
with the implementation by [10]. We used a multivariate normal linear mixed model for longitudinal
variables and a Cox model to relate these and fixed variables to survival estimates. We implemented
two variants of the landmarking approach: one using a traditional Cox survival model [7] and one
using Random Survival Forests (RSF) [11]. We discuss other related work in the Supplement.
Performance evaluation. We use the time-dependent concordance index (C-index) [9] to assess the
discriminative ability of all models,
C(t,∆t) := P
(
Sˆi(t+ ∆t; t) > Sˆj(t+ ∆t; t)|δi = 1, t ≤ Tj , Ti > Tj
)
(5)
The C-index corresponds to the probability that predicted time-to-event probabilities at a time of
interest t+ ∆t are ranked in accordance to the actual observed survival times (at time t+ ∆t), but
evaluated only for those patients still alive at the follow up time t at which predictions are made.
It thus serves as a measure of a model’s discriminative power. The C-index is bounded between
0.5 and 1, 0.5 indicating performance of random guesses and 1 indicating perfect ordering of event
times. In all experiments we implemented BNDS with 50 trees and 1000 samples after a burn-in of
250 samples, our default specification.
Results. We observe in Table 1 that BNDS significantly outperforms all other benchmarks. BNDS
is the only method modelling longitudinal data agnostically and using the whole patient history.
Both Cox-Landmark and JM require specification of variable interactions which strongly limits the
structure they are able to recover from data. This limitation is further illustrated by the performance
gain of RSF-Landmark over Cox-Landmark, arising because the former models variable interactions
more flexibly. Notice also that the performance gap between JM and BNDS (both using the whole
patient history) widens for predictions at later follow ups with respect to cross-sectional models,
thereby highlighting the importance of considering a patient’s history as well as current measurements.
5 Conclusion
We have introduced a Bayesian nonparametric method that is able to use sparse, longitudinal data to
give personalized survival predictions that are updated as new information is recorded. Our modelling
approach has the advantage of providing uncertainty estimates and has the flexibility to model highly
heterogeneous data without a priori modelling choices.
4
References
[1] James H Albert and Siddhartha Chib. Bayesian analysis of binary and polychotomous response
data. Journal of the American statistical Association, 88(422):669–679, 1993.
[2] Eleni-Rosalina Andrinopoulou, Dimitris Rizopoulos, Ruyun Jin, Ad JJC Bogers, Emmanuel
Lesaffre, and Johanna JM Takkenberg. An introduction to mixed models and joint modeling:
analysis of valve function over time. The Annals of thoracic surgery, 93(6):1765–1772, 2012.
[3] Edmon Begoli, Tanmoy Bhattacharya, and Dimitri Kusnezov. The need for uncertainty quan-
tification in machine-assisted medical decision making. Nature Machine Intelligence, 1(1):20,
2019.
[4] Krishnan Bhaskaran, Harriet J Forbes, Ian Douglas, David A Leon, and Liam Smeeth. Rep-
resentativeness and optimal use of body mass index (bmi) in the uk clinical practice research
datalink (cprd). BMJ open, 3(9):e003389, 2013.
[5] Hugh A Chipman, Edward I George, Robert E McCulloch, et al. Bart: Bayesian additive
regression trees. The Annals of Applied Statistics, 4(1):266–298, 2010.
[6] Edward Choi, Mohammad Taha Bahadori, Andy Schuetz, Walter F Stewart, and Jimeng Sun.
Doctor ai: Predicting clinical events via recurrent neural networks. In Machine Learning for
Healthcare Conference, pages 301–318, 2016.
[7] David R. Cox. Regression models and life tables (with discussion). Journal of the Royal
Statistical Society. Series B, 34:187–220, 1972.
[8] Loïc Ferrer, Hein Putter, and Cécile Proust-Lima. Individual dynamic predictions using
landmarking and joint modelling: validation of estimators and robustness assessment. arXiv
preprint arXiv:1707.03706, 2017.
[9] Thomas A Gerds, Michael W Kattan, Martin Schumacher, and Changhong Yu. Estimating a
time-dependent concordance index for survival prediction models with covariate dependent
censoring. Statistics in Medicine, 32(13):2173–2184, 2013.
[10] Graeme L Hickey, Pete Philipson, Andrea Jorgensen, and Ruwanthi Kolamunnage-Dona. Joint
modelling of time-to-event and multivariate longitudinal outcomes: recent developments and
issues. BMC medical research methodology, 16(1):117, 2016.
[11] Hemant Ishwaran, Udaya B Kogalur, Eugene H Blackstone, and Michael S Lauer. Random
survival forests. The annals of applied statistics, pages 841–860, 2008.
[12] Adam Kapelner and Justin Bleich. bartmachine: Machine learning with bayesian additive
regression trees. arXiv preprint arXiv:1312.2171, 2013.
[13] Silvan Licher, Alis Heshmatollah, Kimberly D van der Willik, Bruno H Ch Stricker, Rikje
Ruiter, Emmely W de Roos, Lies Lahousse, Peter J Koudstaal, Albert Hofman, Lana Fani, et al.
Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy
in the general population: A population-based cohort study. PLoS medicine, 16(2):e1002741,
2019.
[14] Keith D Lindor, M Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V Bergasa, and
E Jenny Heathcote. Primary biliary cirrhosis. Hepatology, 50(1):291–308, 2009.
[15] Zachary C Lipton. The doctor just won’t accept that! arXiv preprint arXiv:1711.08037, 2017.
[16] Roderick JA Little and Donald B Rubin. Statistical analysis with missing data, volume 333.
John Wiley & Sons, 2014.
[17] Dimitris Rizopoulos. Dynamic predictions and prospective accuracy in joint models for longitu-
dinal and time-to-event data. Biometrics, 67(3):819–829, 2011.
[18] Judith D Singer and John B Willett. It’s about time: Using discrete-time survival analysis to
study duration and the timing of events. Journal of educational statistics, 18(2):155–195, 1993.
[19] Damian C Stanziano, Michael Whitehurst, Patricia Graham, and Bernard A Roos. A review
of selected longitudinal studies on aging: past findings and future directions. Journal of the
American Geriatrics Society, 58:S292–S297, 2010.
[20] Terry M Therneau and PM Grambsch. Extending the cox model. Edited by P. Bickel, P. Diggle,
S. Fienberg, K. Krickeberg, page 51, 2000.
5
[21] Beth Twala, MC Jones, and David J Hand. Good methods for coping with missing data in
decision trees. Pattern Recognition Letters, 29(7):950–956, 2008.
[22] Hans van Houwelingen and Hein Putter. Dynamic prediction in clinical survival analysis. CRC
Press, 2011.
[23] Hans C Van Houwelingen. Dynamic prediction by landmarking in event history analysis.
Scandinavian Journal of Statistics, 34(1):70–85, 2007.
[24] Hans C Van Houwelingen and Hein Putter. Dynamic predicting by landmarking as an alternative
for multi-state modeling: an application to acute lymphoid leukemia data. Lifetime data analysis,
14(4):447, 2008.
[25] Andrew K Wills, Debbie A Lawlor, Fiona E Matthews, Avan Aihie Sayer, Eleni Bakra, Yoav
Ben-Shlomo, Michaela Benzeval, Eric Brunner, Rachel Cooper, Mika Kivimaki, et al. Life
course trajectories of systolic blood pressure using longitudinal data from eight uk cohorts.
PLoS medicine, 8(6):e1000440, 2011.
6
